28 related articles for article (PubMed ID: 26053727)
1. The role of
Murad H; Ciacoi-Dutu C; Lindblom G; Almquist M
Gland Surg; 2023 Nov; 12(11):1567-1578. PubMed ID: 38107488
[TBL] [Abstract][Full Text] [Related]
2. Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer.
Mu ZZ; Zhang X; Lin YS
Chonnam Med J; 2019 Sep; 55(3):127-135. PubMed ID: 31598469
[TBL] [Abstract][Full Text] [Related]
3. PET/CT in thyroid nodule and differentiated thyroid cancer patients. The evidence-based state of the art.
Piccardo A; Trimboli P; Foppiani L; Treglia G; Ferrarazzo G; Massollo M; Bottoni G; Giovanella L
Rev Endocr Metab Disord; 2019 Mar; 20(1):47-64. PubMed ID: 30900067
[TBL] [Abstract][Full Text] [Related]
4. 18F-choline PET/CT incidental thyroid uptake in patients studied for prostate cancer.
Albano D; Durmo R; Bertagna F; Giubbini R
Endocrine; 2019 Mar; 63(3):531-536. PubMed ID: 30594973
[TBL] [Abstract][Full Text] [Related]
5. Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT.
Thanseer NTK; Bhadada SK; Sood A; Parihar AS; Dahiya D; Singh P; Basher RK; Das A; Mittal BR
Nucl Med Mol Imaging; 2018 Apr; 52(2):154-158. PubMed ID: 29662564
[No Abstract] [Full Text] [Related]
6. Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literature.
Bongiovanni A; Recine F; Celli M; Marcantognini G; Foca F; Liverani C; Fausti V; De Vita A; Miserocchi G; Mercatali L; Amadori D; Ibrahim T
Medicine (Baltimore); 2017 Nov; 96(46):e8567. PubMed ID: 29145267
[TBL] [Abstract][Full Text] [Related]
7. PET/CT imaging of thyroid cancer.
Mosci C; Iagaru A
Clin Nucl Med; 2011 Dec; 36(12):e180-5. PubMed ID: 22064103
[TBL] [Abstract][Full Text] [Related]
8. Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up.
Salvatori M; Biondi B; Rufini V
Eur J Endocrinol; 2015 Sep; 173(3):R115-30. PubMed ID: 25947140
[TBL] [Abstract][Full Text] [Related]
9. Role of
Piccardo A; Trimboli P; Puntoni M; Foppiani L; Treglia G; Naseri M; Bottoni GL; Massollo M; Sola S; Ferrarazzo G; Bruzzone M; Catrambone U; Arlandini A; Paone G; Ceriani L; Cabria M; Giovanella L
Thyroid; 2019 Apr; 29(4):549-556. PubMed ID: 30864903
[TBL] [Abstract][Full Text] [Related]
10. The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan.
Trybek T; Kowalska A; Lesiak J; Młynarczyk J
Nucl Med Rev Cent East Eur; 2014; 17(2):87-93. PubMed ID: 25088108
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.
Nakajo M; Nakajo M; Jinguji M; Tani A; Kajiya Y; Tanabe H; Fukukura Y; Nakabeppu Y; Koriyama C
Radiology; 2013 Jun; 267(3):891-901. PubMed ID: 23468571
[TBL] [Abstract][Full Text] [Related]
12. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Weber T; Ohlhauser D; Hillenbrand A; Henne-Bruns D; Reske SN; Luster M
Horm Metab Res; 2012 Nov; 44(12):904-8. PubMed ID: 22791600
[TBL] [Abstract][Full Text] [Related]
13. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
Ozkan E; Aras G; Kucuk NO
Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
[TBL] [Abstract][Full Text] [Related]
14. Lymph Node Metastasis from Tall-Cell Thyroid Cancer Negative on 18F-FDG PET/CT and Detected by 18F-Choline PET/CT.
Piccardo A; Massollo M; Bandelloni R; Arlandini A; Foppiani L
Clin Nucl Med; 2015 Aug; 40(8):e417-9. PubMed ID: 26053727
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
